EEnsoData provides a SaaS platform that uses AI to analyze sleep-wake waveform data for medical diagnostics. Its flagship EnsoSleep automates sleep-study scoring by analyzing signals (EEG, ECG, and other sensors) and supports in-lab and home studies, including the EnsoSleep PPG option for sleep apnea. The system integrates with existing sleep-lab software and electronic health records to streamline clinician workflows. Its goal is to improve diagnostic efficiency and accuracy in sleep medicine and to expand into related areas like cardiology and neurology with scalable AI-powered clinical decision support.
Work here?Claim your company
Industries
Company Size
51-200
Company Stage
Series B
Total Funding
$51.1M
Headquarters
Madison, WI
Founded
2015
See people who can refer or advise you
Help us improve and share your feedback! Did you find this helpful?
Total Funding
$51M
Below
Industry Average
Funded Over
5 Rounds
Industry standards
AASM announces first autoscoring certification awarded to EnsoData. DARIEN, IL - The American Academy of Sleep Medicine congratulates EnsoData on becoming the first company to achieve Full PSG Certification through the AASM Autoscoring Certification Program, with EnsoSleep Version 8.3 certified across all four scoring domains: sleep staging, arousals, respiratory events and periodic limb movements. The program independently evaluates autoscoring software performance against rigorous AASM standards using a large dataset of real-world polysomnography studies. Certification was awarded to EnsoSleep Version 8.3, recognizing the software's demonstrated performance across the complete PSG scoring process and supported home sleep apnea test applications. "The AASM Autoscoring Certification Program was created to provide an independent, objective assessment of autoscoring software performance and to help sleep centers identify solutions they can trust," said Steve Van Hout, executive director of the AASM. "We congratulate EnsoData on this important achievement and for becoming the first company to successfully complete certification across all four scoring domains." EnsoData previously participated in the AASM Sleep Stage Autoscoring Pilot Program, which helped inform the development of the current certification framework. The certification of EnsoSleep Version 8.3 represents a significant milestone in the evolution of independent performance validation for sleep technology and highlights the growing role of artificial intelligence and automation in sleep medicine. "As autoscoring technology continues to become integrated into clinical workflows, independent validation is increasingly important," said Dr. Fariha Abbasi-Feinberg, president of the AASM. "Achievements such as this help advance transparency, innovation and confidence in technologies that support patient care." About the AASM Autoscoring Certification Program. The AASM Autoscoring Certification Program provides an independent, objective evaluation of autoscoring software used to analyze PSG records and HSAT results. The program helps sleep centers and clinicians identify software that has demonstrated performance comparable to expert human scorers while promoting innovation, transparency and quality within sleep medicine. Individual domain autoscoring certification. Under AASM certification standards, individual domain certification enables companies to certify their software in one or more of these domains: sleep stage, arousals, respiratory events and leg movements. This modular approach expands the scope of eligibility beyond PSG-only software to include HSAT solutions. Full PSG autoscoring certification. Software that successfully meets performance requirements for all four scoring parameters receives Full PSG Certification. The AASM is currently accepting applications for the Autoscoring Certification Program. To be eligible, autoscoring software must have received 510(k) clearance from the Food and Drug Administration or be in the submission process, and it must be capable of analyzing raw, unscored, full-night polysomnography records. Companies that achieve certification will receive a certificate, be permitted to use the autoscoring certification mark for promotional purposes and have their software recognized on the AASM website. About the American Academy of Sleep Medicine Established in 1975, the AASM is a medical association that advances sleep care and enhances sleep health to improve lives. The AASM membership includes more than 9,500 physicians, scientists, and other health care professionals who help people who have sleep disorders. The AASM also accredits 2,300 sleep centers that are providing the highest quality of sleep care across the country.
New direct-to-patient home sleep testing workflow aims to scale clinic capacity. A newly launched diagnostic model handles device shipping and patient support, allowing practitioners to focus on clinical interpretation and program growth. Key takeaways: * EnsoData's new direct-to-patient service offers up to 7 nights of testing to mitigate night-to-night variability. * AI-scored results are generated in minutes, featuring a 1 to 5-day turnaround from order to results. * The model eliminates device handling for clinics while allowing them to interpret studies and control billing workflows. EnsoData recently released EnsoHST Direct, a fully managed diagnostic workflow that enables practitioners to scale testing capacity without buying or managing devices. The service uses EnsoHST devices and ships directly to the patient, providing setup and support. To help mitigate night-to-night variability, up to 7 nights of testing are available. Following each test, patients receive an in-app notification either confirming a successful study or prompting them to test for an additional night, which helps deliver a 97% patient success rate, according to the company. Once the testing period is complete, artificial intelligence-scored results are generated in minutes. According to the company, these results offer high clinical precision, including 92% sensitivity for sleep apnea, 100% specificity for moderate CSA, +/-1 mean eAHI, and a 5.5-minute average difference between EnsoHST total sleep time and PSG. Overall turnaround time is 1 to 5 days from order date to results date. While EnsoData handles the logistics and device management, the sleep practice or lab processes patient payment. The company notes that providers should choose this model if they want to: * Eliminate device handling and shipping logistics * Remove patient setup burden from your staff * Interpret studies yourself * Control billing workflows * Scale without hiring additional team members * Accelerate testing without increasing internal complexity "Our primary goal with EnsoHST Direct is to eliminate the operational friction that has historically capped the growth of home sleep testing programs while finally making multi-night diagnostics accessible," says Bobby Cockrill, MBA, chief commercial officer at EnsoData. "By taking the entire burden of shipping, device management, and patient support off the clinic's shoulders, Medqor Llc. is empowering healthcare providers to focus on what matters most: clinical interpretation and patient care. "This fully managed, end-to-end workflow allows sleep programs and health systems to overcome the clinical limitations of single-night testing and capture a true longitudinal picture of a patient's sleep health, while scaling testing capacity without adding internal headcount or complexity."
CIBC Innovation Banking announced today that it has provided growth capital financing for EnsoData, a leading provider of AI-powered software solutions for s...
Services financiers Innovation CIBC has provided growth capital to EnsoData, a leading provider of AI-powered software solutions for sleep medicine. The financial terms of the investment were not disclosed. EnsoData develops artificial intelligence technology that assists healthcare providers in diagnosing and treating sleep disorders. The company's software solutions aim to streamline clinical workflows and improve diagnostic accuracy in sleep medicine. The investment from CIBC Innovation Banking will support EnsoData's continued growth and expansion of its AI-driven sleep medicine platform. CIBC Innovation Banking specialises in providing financing to technology and innovation-focused companies across various sectors.
CIBC Innovation Banking provides growth capital to EnsoData. * Business Wire * May 12, 2026 * 0 MADISON, Wis.-(BUSINESS WIRE)-May 12, 2026- CIBC Innovation Banking announced today that it has provided growth capital financing for EnsoData, a leading provider of AI-powered software solutions for sleep medicine. EnsoData is advancing sleep medicine through AI-powered, FDA-cleared solutions that help simplify diagnosis and expand access to care. Its flagship product, EnsoHST, is a clinically proven, multi-night home sleep testing solution that uses a simple wearable device and mobile app to deliver fast, clinically reliable results. By automating analysis and removing operational friction, EnsoData enables clinicians to expand capacity, accelerate diagnosis, and improve patient outcomes. "This facility from CIBC Innovation Banking enables EnsoData to expand access to the sleep care pathway today, while accelerating our investment in AI-driven innovations that will shape the future of diagnostics across multiple clinical domains," said Matt Dobereiner, CFO of EnsoData. "CIBC Innovation Banking is very glad to support EnsoData's growth and continued adoption among sleep medicine professionals," said Andrew Schwartz, Managing Director, CIBC Innovation Banking. "EnsoData is at the exciting intersection of leveraging AI and machine-learning technology to improve access for patients to the care pathway." About CIBC Innovation Banking CIBC Innovation Banking has 25 years of specialized experience in growth-stage tech and life science companies across North America - a longer track record than most banks. CIBC Innovation Banking now has over $11 billion in funds managed including life sciences, health care, cleantech companies, investors, and entrepreneurs, and has assisted over 700 venture and private equity-backed businesses over the past six and a half years. The bank operates out of 14 global locations in San Francisco, Menlo Park, New York, Toronto, London, Austin, Boston, Chicago, Seattle, Vancouver, Montreal, Atlanta, Reston, and Durham. Connect with us today to start the conversation. Innovationbanking.cibc.com About EnsoData EnsoData is a healthcare technology company advancing sleep medicine through artificial intelligence. Its solutions support the full sleep care continuum, from diagnosis through long-term patient management, enabling clinicians to improve efficiency and expand access to care. EnsoData is also exploring applications across additional clinical areas. To date, EnsoData's technology has supported the care of more than 2.9 million patients. https://ensodata.com Katarina Milicevic,[email protected], 416-362-3458 KEYWORD: WISCONSIN UNITED STATES NORTH AMERICA CANADA INDUSTRY KEYWORD: BANKING TECHNOLOGY PROFESSIONAL SERVICES HEALTH VENTURE CAPITAL HEALTH TECHNOLOGY APPS/APPLICATIONS SOFTWARE ARTIFICIAL INTELLIGENCE MOBILE/WIRELESS FINANCE PUB: 05/12/2026 07:00 AM/DISC: 05/12/2026 07:00 AM
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs
Industries
Company Size
51-200
Company Stage
Series B
Total Funding
$51.1M
Headquarters
Madison, WI
Founded
2015
Find jobs on Simplify and start your career today
Don't see your dream role? Check out thousands of other roles on Simplify.Browse all jobs